Cardiovascular Disease in Women: Why Symptoms Differ from Men
Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS
Cardiovascular disease in women often presents with atypical symptoms compared to men, driven by sex-specific pathophysiological differences like microvascular dysfunction and hormonal influences, leading to under-recognition and delayed diagnosis.
Cardiovascular disease (CVD) remains the leading cause of death for women globally, yet it is often under-recognized, under-diagnosed, and undertreated in this population. A critical factor contributing to this disparity is the significant difference in how CVD, particularly myocardial infarction (heart attack), manifests in women compared to men. These symptomatic differences are not merely anecdotal but are rooted in distinct pathophysiological mechanisms, hormonal influences, and anatomical variations, necessitating a sex-specific approach to diagnosis and management.
Atypical Symptoms of Myocardial Infarction in Women
While the classic symptom of a heart attack – crushing chest pain radiating to the left arm – is often depicted, women are more likely to experience a broader and often 'atypical' constellation of symptoms. This can lead to delayed presentation to emergency care and misdiagnosis [1].
Common atypical symptoms in women include:
Shortness of Breath: Often occurring without chest pain, or preceding it.
Nausea and Vomiting: Gastrointestinal symptoms are more prevalent in women.
Back, Neck, Jaw, or Arm Pain: Pain can be localized to these areas, rather than the chest.
Unusual Fatigue: Profound, unexplained fatigue, sometimes for days or weeks leading up to an event.
Lightheadedness or Dizziness: Feeling faint or dizzy.
Sweating: Cold sweats unrelated to exertion or temperature.
Sleep Disturbances: Difficulty sleeping or unusual sleep patterns.
It is crucial to note that women can and do experience chest pain, but it may be less severe, described as pressure or tightness rather than crushing, and often accompanied by other symptoms [2].
Pathophysiological Differences
The symptomatic divergence is underpinned by fundamental biological differences between sexes in the development and manifestation of CVD.
Men: More commonly experience obstructive CAD, characterized by significant blockages in the large epicardial coronary arteries due to atherosclerotic plaque rupture.
Women: Are more likely to have non-obstructive CAD, including coronary microvascular dysfunction (CMD) and spontaneous coronary artery dissection (SCAD) [3].
CMD: Involves dysfunction of the small blood vessels that branch off the major coronary arteries. This can lead to angina (chest pain) and myocardial ischemia (reduced blood flow to the heart muscle) even in the absence of significant blockages in larger arteries. CMD is more prevalent in women and often presents with atypical symptoms [4].
SCAD: A tearing in the wall of a coronary artery that is not caused by atherosclerosis. It is a significant cause of heart attack in younger women, particularly peripartum women, and often presents with symptoms similar to typical MI [5].
Estrogen's Protective Role: Pre-menopausal estrogen has cardioprotective effects, including favorable lipid profiles, improved endothelial function, and anti-inflammatory properties. The decline in estrogen after menopause significantly increases women's CVD risk, often shifting the risk profile to resemble that of men, but with different manifestations [6].
Inflammation: Women tend to have a more pronounced inflammatory response to cardiovascular stressors, which can contribute to plaque instability and microvascular dysfunction.
Traditional Risk Factors: While traditional risk factors like hypertension, diabetes, dyslipidemia, and smoking are common to both sexes, their impact and prevalence can differ. For example, diabetes confers a higher relative risk for CVD in women than in men [7].
Sex-Specific Risk Factors: Women have unique CVD risk factors, including preeclampsia, gestational diabetes, polycystic ovary syndrome (PCOS), and autoimmune diseases (e.g., lupus, rheumatoid arthritis), which significantly increase their lifetime risk of CVD [8].
Clinical Implications and Improving Outcomes
The differences in symptoms and pathophysiology have critical implications for clinical practice:
Increased Awareness: Healthcare providers must be highly aware of the diverse presentations of CVD in women to avoid misdiagnosis or delayed treatment.
Sex-Specific Diagnostic Tools: Traditional diagnostic tests (e.g., exercise stress tests, standard angiography) may be less sensitive in detecting CMD or non-obstructive CAD in women. Advanced imaging techniques (e.g., cardiac MRI, PET scans) and functional testing may be more appropriate [9].
Tailored Treatment Strategies: Treatment approaches may need to be individualized, considering the underlying pathophysiology. For example, therapies targeting microvascular dysfunction may be more relevant for some women.
Patient Education: Women need to be educated about their unique risk factors and the varied symptoms of heart attack to empower them to seek timely medical attention.
Research Focus: Continued research into sex-specific differences in CVD is essential to develop better diagnostic tools, prevention strategies, and treatments for women.
Conclusion
Cardiovascular disease in women is a distinct entity from that in men, characterized by differences in symptomatic presentation and underlying pathophysiology. The higher prevalence of atypical symptoms, coupled with conditions like coronary microvascular dysfunction and unique hormonal influences, contributes to under-recognition and poorer outcomes. By fostering greater awareness, employing sex-specific diagnostic approaches, and tailoring treatment strategies, clinicians can bridge the existing gaps in care and significantly improve cardiovascular health outcomes for women.